Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Titel:
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
Auteur:
Cahn, A. Hamblin, J.N. Begg, M. Wilson, R. Dunsire, L. Sriskantharajah, S. Montembault, M. Leemereise, C.N. Galinanes-Garcia, L. Watz, H. Kirsten, A.M. Fuhr, R. Hessel, E.M.